Ambu Inc. is accelerating its share of the single-use endoscope market through a newly awarded contract in the category of single-use visualization devices with Vizient Inc., a healthcare performance improvement company. The agreement is effective Feb. 1, 2022.
Vizient’s members represent more than half of the hospitals and health systems in the U.S and serve 97 percent of all the academic medical centers.
The contract with Vizient is designed to accelerate Ambu’s share of the single-use endoscope market by offering Vizient members pre-negotiated pricing and terms for Ambu’s full suite of single-use products in Bronchoscopy, Urology, ENT and GI. This agreement also includes access to all new single use endoscopy launches.
The creation by GPOs of specific single-use endoscope categories comes as the transition to single-use endoscopy continues to accelerate, with an eye on expanding hospitals’ capacity and avoiding costly and unnecessary expenses associated with workflow management and patient cross-contamination.
“Our vision at Ambu is to be the most innovative single-use endoscopy company and this agreement with Vizient enables us to better serve its member health systems, hospitals, and healthcare providers across the U.S.,” says Juan Jose Gonzalez, CEO of Ambu A/S. “We consider Vizient an exceptional company and are excited to work closely with its member organizations. Our portfolio breadth, innovation ecosystem and attractive economics mean we can be the partner of choice for health systems in their efforts to prevent device-related infections, boost healthcare economics and improve clinical workflows.”
Ambu launched its single-use flexible bronchoscope, the Ambu aScope, in 2009. A decade later, in fiscal 2020/2021, more than 1.5 million Ambu single-use endoscopes were used around the world.
